Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.
about
Epstein Barr virus/complement C3d receptor is an interferon alpha receptorT lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE)Infectious diseases associated with complement deficiencies.Mapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.Identification of murine complement receptor type 2Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells.Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pairHepatitis B and hepatitis C co-infection in patients with HIV.Clinicopathological spectrum of Epstein-Barr virus-associated T cell malignancies.Generation of stable human autoantibody-secreting B cell hybridomas.Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus.Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cells.Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors.Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection.Virus-lymphocyte interactions: inductive signals necessary to render B lymphocytes susceptible to vesicular stomatitis virus infection.Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2Pathogenic anti-DNA antibodies in SLE: idiotypic families and genetic origins.Complement, C receptors, and immune complex disease.Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma.Assays for membrane complement receptors.The influence of C3-coated homologous erythrocytes on pokeweed-mitogen-induced polyclonal differentiation of human B cells.C3d and Epstein-Barr virus (CR2/CD21 ligands) stimulate cells of an HTLV-I line, MT-2.Expression of complement receptor 2 (CR2) on HTLV-1-infected lymphocytes and transformed cell lines.Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1.Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia.Malignant plasma cell tumors in human immunodeficiency virus-infected patients.CD21S antigen expression in tumour cells of diffuse large B-cell lymphomas is an independent prognostic factor indicating better overall survival.A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in mice.
P2860
Q24561504-4FF718FC-AD4D-4F5A-B975-A5376C1C8253Q24672100-8BCAD7DB-8589-4DE9-BB29-4B75A3C6644CQ30450183-36A8ED7D-A8C8-460E-8AED-6EA5FE929886Q33402381-849F3FA3-B6C7-4401-99A7-BD298628917DQ33829140-4F1B7615-9305-4D02-A62C-04B17FF830BEQ33848157-7B70A698-0472-4388-A8A4-63C3CCF72A07Q34094547-EA3CE3FC-B8F7-4457-A021-9A21BA58DD72Q34323219-C8B07E3F-6BF6-459A-A549-EC8F64A1F3F2Q35237191-732BF406-031A-4722-B9D6-5189B8092370Q36220156-91BB8519-4895-4BE0-A11F-B2BDE016B1E9Q36362069-4F240E9D-3EC4-4ABA-9D9F-0CD0234FC0CCQ36623632-7EA427A0-9ABB-4C70-9DDF-026CC8B999D5Q36645449-43E19133-C4FC-4443-984A-AAA061974A4BQ36691265-90A35FA8-C31B-4875-BE4B-84613AC61848Q36802659-0B56F525-5ADA-4C6F-97D8-8517202E5083Q36809921-52911D51-32B7-424D-B2B7-91CF08DC5B73Q36963833-EF0615D7-2907-4066-9D11-241556B8CC35Q37868736-E22C9E2F-658B-4DA5-A8EB-9E888A21423FQ39486877-57EE6374-E8D3-4B4C-97C4-2FA68572C6E7Q39861902-CE7B2078-92C3-46EE-9116-120A59918674Q39989112-BC0063CB-7AA8-432B-A8AD-24604CC48AC1Q41266502-DC445A4F-D0B1-49CD-BEEE-8F9B3E66AB16Q41393078-4A242251-9740-4262-A8A9-747AC48E91B1Q41548829-64BB2602-1A53-4958-A43B-2C36C1A4E38DQ41561745-31F79C02-BBD3-4EC5-805C-8315EB9599BDQ41627645-00AE4752-4B26-4812-92E3-502C70B7C4FEQ41644730-624D65CD-FFCE-4779-940D-17BDB4C5756EQ41689555-ECF8F0E6-CFBE-456C-9587-4CB3D421C80EQ43460280-334060BC-FD21-4F9C-BB45-7874CCA9FB48Q44826302-6D2DD176-5287-4727-A6AE-CE0D1F899CAFQ47669801-2F063072-2427-4B6C-A80C-F49EE0B583DF
P2860
Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Immunobiology of CR2, the B ly ...... d the C3d complement fragment.
@en
Immunobiology of CR2, the B ly ...... d the C3d complement fragment.
@nl
type
label
Immunobiology of CR2, the B ly ...... d the C3d complement fragment.
@en
Immunobiology of CR2, the B ly ...... d the C3d complement fragment.
@nl
prefLabel
Immunobiology of CR2, the B ly ...... d the C3d complement fragment.
@en
Immunobiology of CR2, the B ly ...... d the C3d complement fragment.
@nl
P2093
P1476
Immunobiology of CR2, the B ly ...... d the C3d complement fragment.
@en
P2093
P304
P356
10.1146/ANNUREV.IY.06.040188.000505
P577
1988-01-01T00:00:00Z